A Singapore-based biotechnology business creating innovative cell treatments for cancer therapy was expanding from clinical to commercial operations. Their former IT systems lacked the adaptability and compliance tools required for this new stage. They required a smart ERP system that could enable GxP-compliant manufacturing, worldwide procurement, and investor openness as they were ready for commercial supply chain growth and worldwide regulatory clearances.
Business Challenges:
- Legacy systems lacked flexibility for scaling and regulatory compliance
- Inability to support commercial operations and investor reporting
- Need for standardized operating procedures across functions
- Limited readiness for GxP-compliant pharma manufacturing
Client Type: Biotechnology Company
Technologies Used: SAP S/4HANA, SAP ERP, SAP BTP
RiseAscend Suggestions:
RiseAscend suggested a GxP-aligned SAP deployment to standardise SOPs and assist expansion and regulatory readiness as the customer moved from clinical to commercial operations. We counselled on creating a worldwide ERP backbone integrating finance, procurement, and supply chain so that costs could be seen, traceable, and integrated across all three areas, therefore enabling the business to satisfy market needs and ensure long-term compliance.
Solution Provided:
RiseAscend implemented SAP S/4HANA and SAP BTP to:
- Automate procurement, supply chain, and financial operations
- Ensure regulatory traceability and audit readiness
- Enable standardized SOPs and validation frameworks
- Support market strategy execution with cost and performance tracking
Outcome:
- Streamlined global operations and reduced regulatory risk
- Improved cost control and decision-making visibility
- GxP-compliant ERP foundation supporting sustainable growth
